| Application no. and date | 12703670.5 (espacenet) (Federated) (European Patent Register), 20120202 | | Patent/reg. no. and date | DK/EP 2670401, 20150610 | | Publication date | 20131211 | | Priority no. and date | US 201161438878 P, 20110202 | | EP pub. no. and date |
EP 2670401 20131211 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | 151488/NGC/AP | | Inventor | LI, Nanxin, Genomics Institute of the Novartis Research
Foundation
10675 John Jay Hopkins Drive
San Diego
California 92121, US,
HARRIS, Jennifer L., Genomics Institute of the Novartis Research
Foundation
10675 John Jay Hopkins Drive
San Diego
California 92121, US,
McNAMARA, Peter, Genomics Institute of the Novartis Research
Foundation
10675 John Jay Hopkins Drive
San Diego
California 92121, US,
SUN, Fangxian, 4 Cedarwood Lane
Melrose
Massachusetts 02176, US | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/00 (2006.01) , A61K 31/506 (2006.01) , A61P 35/00 (2006.01) , C07D 401/12 (2006.01) , C07D 401/14 (2006.01) | | Title | Fremgangsmåder til anvendelse af ALK-inhibitorer | | Int. application no. | US2012023669 | | Int. publication no. | WO2012106540 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
